Mutation analysis by the use of temporal temperature gradient gel electrophoresis

Turkish Journal of Medical Sciences

Volumn 35, Issue 5, 2005, Pages 279-282

  Alper, Özgül M ^a   Lüleci, Güven ^a   Wong, Lee Jun C ^b  

^a AKDENIZ UNIVERSITY   (Turkey)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Mitochondrial mutations; Molecular scanning; Mutation; Mutation detection techniques; Nuclear gene

Indexed keywords

DNA; DNA FRAGMENT; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ARTICLE; CRANIOFACIAL SYNOSTOSIS; CYSTIC FIBROSIS; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; GEL ELECTROPHORESIS; GENE SEQUENCE; GENETIC COUNSELING; GENETIC POLYMORPHISM; HEARING IMPAIRMENT; HETEROZYGOSITY; HETEROZYGOTE DETECTION; HOMOZYGOSITY; IONIC STRENGTH; MELTING POINT; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; PRENATAL DISORDER; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TEMPERATURE DEPENDENCE;

EID: 32544458025     PISSN: 13000144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Myers RM, Maniatis T, Lerman LS. Detection and localization of single base changes by denaturing gradient gel electrophoresis. Methods Enzymol 155: 501-527, 1987.
2. Yoshino K, Nishigaki K, Husimi Y. Temperature sweep gel electrophoresis: a simple method to detect point mutations. Nucleic Acids Res 19: 3153, 1991.
3. Wartell RM, Hosseini S, Powell S et al. Detecting single base substitutions, mismatches and bulges in DNA by temperature gradient gel electrophoresis and related methods. J Chromatogr A 806: 169-85, 1998.
4. Orita M, Suzuki Y, Sekiya T et al. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5: 874-9, 1989.
5. Tassabehji M, Read AP, Newton VE et al. Mutations in the PAX3 gene causing Waardenburg syndrome type 1 and type 2. Nat Genet 3: 26-30, 1993.
6. Saleeba JA, Ramus SJ, Cotton RG. Complete mutation detection using unlabeled chemical cleavage. Hum Mutat 1: 63-9, 1992.
7. Sheffield VC, Beck JS, Kwitek AE et al. The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitutions. Genomics 16: 325-32, 1993.
8. Ferec C, Le Marechal C, Audrezet MP et al. Analysis of genomic CFTR DNA. J Cyst Fibros 3 Suppl 2: 7-10, 2004.
9. Wong LJ, Alper O, Kwon HY, Tan DJ, Chen TJ. Temporal temperature gradient gel electrophoresis, Encyclopedia of Diagnostic Genomics and Proteomics, Marcel Dekker, Inc, 2004.
10. Cotton RG. Methods in clinical molecular genetics. Eur J Pediatr 159 Suppl 3: S179-82, 2000.
11. Kozlowski P, Krzyzosiak WJ. Structural factors determining DNA length limitations in conformation-sensitive mutation detection methods. Electrophoresis 26: 71-81, 2005.
12. Mogensen J, Bahl A, Kubo T et al. Comparison of fluorescent SSCP and denaturing HPLC analysis with direct sequencing for mutation screening in hypertrophic cardiomyopathy. J Med Genet 40: 59, 2003.
13. Sozen M, Whittall R, Humphries SE. Mutation detection in patients with familial hypercholesterolaemia using heteroduplex and single strand conformation polymorphism analysis by capillary electrophoresis. Atheroscler Suppl 5: 7-11, 2004.
14. Wong LJ, Alper OM. Detection of CFTR mutations using temporal temperature gradient gel electrophoresis. Electrophoresis 25: 2593-601, 2004.
15. Wong LJ, Wang J, Zhang YH et al. Improved detection of CFTR mutations in Southern California Hispanic CF patients. Hum Mutat 18: 296-307, 2001.
16. Verheij JB, Wildhagen MF, Hofstra RM et al. Preconceptional screening of couples for carriers of cystic fibrosis: a prospective evaluation of effects, costs and savings for different mutation detection methods. Community Genet 2: 74-81, 1999.
17. Liechti-Gallati S, Schneider V, Neeser D et al. Two buffer PAGE system-based SSCP/HD analysis: a general protocol for rapid and sensitive mutation screening in cystic fibrosis and any other human genetic disease. Eur J Hum Genet 7:590-8, 1999.
18. Alper OM, Wong LJ, Young S et al. Identification of novel and rare mutations in California Hispanic and African American cystic fibrosis patients. Hum Mutat 24:353, 2004.
19. Lin T, Orrison BM, Suchy SF et al. Mutations are not uniformly distributed throughout the OCRL1 gene in Lowe syndrome patients. Mol Genet Metab 64: 58-61, 1998.
20. Wong LJ, Liang MH, Kwon H et al. Comprehensive scanning of the entire mitochondrial genome for mutations. Clin Chem 48: 1901-12, 2002.
21. Chen TJ, Boles RG, Wong LJ. Detection of mitochondrial DNA mutations by temporal temperature gradient gel electrophoresis. Clin Chem 45: 1162-7, 1999.
22. Bayazit YA, Cable BB, Cataloluk O et al. GJB2 gene mutations causing familial hereditary deafness in Turkey. Int J Pediatr Otorhinolaryngol 67: 1331-5, 2003.
23. Kilinc MO, Ninis VN, Daǧli E et al. Highest heterogeneity for cystic fibrosis: 36 mutations account for 75% of all CF chromosomes in Turkish patients. Am J Med Genet 113: 250-7, 2002.
24. Alper OM, Shu SG, Lee MH et al. Detection of novel CFTR mutations in Taiwanese cystic fibrosis patients. J Formos Med Assoc 102: 287-91, 2003.
25. Alper OM, Wong LJ, Hostetter G et al: 1154insTC is not a rare CFTR mutation. Am J Med Genet A 120: 294-5, 2003.